Metabiologics, Inc.

505 S. Rosa Rd.
Madison, WI 53719
3 Employees

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $656K
First Award Date 09/02/99
Most Recent Award Date 09/01/02

Key Personnel

Last Name Name Awards Contact
Goodnough Dr. Michael C. Goodnough 4

4 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: RFA-AI-02-05
Budget: 09/01/02 - 08/31/03

DESCRIPTION (provided by applicant): There currently are no commercially available systems for specific delivery of pharmaceuticals to motor neurons. Many drugs that have potentially beneficial uses in treating disorders of the cholinergic nervous system are unavailable for use in motor neuron diseases due to drawbacks such as insolubility prob...

Phase 2 STTR

Institution: University of Wisconsin, Madison

Agency: Army
Topic: A99T009
Budget: 06/12/00 - 11/11/02

The seven toxin serotypes of Clostridium botulinum neurotoxin are the most potent substances known to mankind. The neurotoxins act on cholinergic neurons inhibiting the release of acetylycholine causing flaccid paralysis due to the inability of the enervated muscle to contract At present there is no known treatment for non-immunized individuals...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/99 - 03/29/00

DESCRIPTION: (Verbatim from the Applicant's Abstract) The mammalian nervous system is an extremely complicated network of tissues making targeting of selected biological active compounds to specific portions of the system extremely difficult. The primary difficulty in targeting neurons for treatment with sp...

Phase 1 STTR

Institution: University of Wisconsin, Madison

Agency: Army
Topic: A99T009
Budget: 09/02/99 - 02/29/00

The seven toxin serotypes of Clostridium botulinum are the most potent substances known to mankind. The neurotoxins act on cholinergic neurons inhibiting the release of acetylcholine causing flaccid paralysis due to, the inability of the inverted muscle to contract. At present there is no known treatment for non-immunized individuals exposed t...